By virtue of a very evil and creative loophole in the FDA regulations covering novel products gmo foods were able to be classified as "substantial equivalent" to traditional foods.
This cleverly contorted legal definition provided that based on nutrient measures of novel gmo being within range of food crops with a history of safe use they would be allowed into the American food supply without safety testing.
Since 1997 gmo crops have enjoyed untested, secret status in the USA foods, but now the first long term animal study is revealing toxic effects and the scientist has been under attack for results.
The controversial study author is Seralini and industry members inside the EFSA have tried to defend Monsanto gmo corn and this is the latest volley in the heating battle.
Bias in assessing scientific evidence for risks of genetically engineered plants
30. October 2012
Munich
In a new backgrounder, Testbiotech shows that the European Food Safety Authority (EFSA) uses double standards in assessing scientific publications. According to an analysis presented today, the authority applies differing standards to assess risks of genetically engineered plants and EFSA´s findings appear to be influenced by assumptions.
Recently published research on long term animal feeding trials using genetically engineered maize (NK603) and the herbicide Roundup. The scientists identified signals for severe health impacts in rats (Séralini et al. 2012). The results were rejected by EFSA for not meeting scientific standards such as, for example, those set out by the OECD.
However, detailed analysis shows that on a number of occasions in the past, EFSA has accepted publications that were not in accordance with the scientific standards now being used by EFSA to criticise the French study. The results from these previous studies did not identify health risks and were adopted without criticism. This inconsistency suggests that EFSA is ‘cherry picking’ when it comes to which scientific standards it chooses to apply.
“The way publications are assessed by EFSA seems to be biased by an assumption that products like genetically engineered plants should be regarded as being safe”, says Christoph Then of Testbiotech. “It looks like EFSA is using the debate about scientific standards to defend their own previous opinions which concluded that there are no risks for human health.”
According to Testbiotech, the scientific standards used in the feeding study by Séralini et al. (2012) are higher than those used in previous studies, even though the recent French study has some weakness in methodology. In conclusion, the results should be taken seriously and be a starting point for further investigations. Given that consumers could be exposed to the controversial products on a daily basis, a high level of precaution is necessary.
In view of the debate arising around the French study, Testbiotech is urging that the standards used in recent years for the risk assessment of genetically engineered plants and pesticides should be revised and reshaped in order to achieve a higher level of protection for consumers and the environment. Furthermore, independent risk research should be given much higher priority in EU research programs.
